With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

We recently published a list of Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks. In this article, we are going to ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.